Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced that they acquired marketing and distribution rights to an ANDA filing from KVK-Tech, Inc. for dexbrompheniramine maleate 6mg/pseudoephedrine sulfate 120 mg extended release tablets. The product will be marketed by ECR, Hi-Tech's branded sales and marketing company under the Lodrane brand name.

David Seltzer, Hi-Tech's president and CEO said, “We are pleased to have the near-term opportunity to introduce through ECR an extended release antihistamine/decongestant. The product is similar to our Lodrane brand products and will allow us to leverage significant equity in the brand, particularly as approximately 500 unapproved cough/cold and allergy products will be removed from the market in September 2011.”

Hi-Tech is a specialty pharmaceutical company developing, manufacturing and marketing generic, branded prescription and OTC products. The Company specializes in difficult to manufacture liquid and semi-solid dosage forms and produces a range of sterile ophthalmic, otic and inhalation products.